Considerations on Discontinuing Natalizumab for the Treatment of Multiple Sclerosis

J.R. Berger, D. Centonze, G. Comi, C. Confavreux, G. Cutter, G. Giovannoni, R. Gold, H.P. Hartung, F. Lublin, A. Miravalle, X. Montalban, P. O'Connor, T. Olsson, C.H. Polman, O. Stuve, J.S. Wolinsky, T. Ziemssen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)409-411
JournalAnnals of Neurology
Volume68
Issue number3
DOIs
Publication statusPublished - 2010

Cite this

Berger, J. R., Centonze, D., Comi, G., Confavreux, C., Cutter, G., Giovannoni, G., ... Ziemssen, T. (2010). Considerations on Discontinuing Natalizumab for the Treatment of Multiple Sclerosis. Annals of Neurology, 68(3), 409-411. https://doi.org/10.1002/ana.22083